Union Savings Bank’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Union Savings Bank's BIIB Position: Q4 2024 in Review
Union Savings Bank sold out of Biogen (BIIB) in Q4 2024, closing a stake of 145 shares — an estimated $28.1K sold.
Union Savings Bank first reported a position in BIIB in Q2 2023 and held it in 6 quarters. The position peaked at $39.2K in Q2 2023. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.
- Union Savings Bank reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
- Union Savings Bank sold 145 Biogen shares in Q4 2024, an estimated $28.1K.
- Union Savings Bank first reported a position in Biogen in Q2 2023 and held it in 6 quarters.
- Union Savings Bank's Biogen position peaked at $39.2K in Q2 2023.
- 876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.
Based on Union Savings Bank's 13F filing for Q4 2024, filed 16 Jan 2025.